Search results for " tricuspid regurgitation"

showing 3 items of 3 documents

First-in-Human Percutaneous Circumferential Annuloplasty for Secondary Tricuspid Regurgitation

2020

Transcatheter therapies to treat tricuspid regurgitation are being developed, but few have attempted the gold standard of surgical repair: ring annuloplasty. We describe the first-ever fully percutaneous implantation of a circumferential, semirigid annuloplasty ring to treat massive secondary tricuspid regurgitation. (Level of Difficulty: Advanced.)

0301 basic medicinemedicine.medical_specialtyPercutaneousRDS ring delivery systemTR tricuspid regurgitationCase ReportRegurgitation (circulation)030105 genetics & heredityelectrocardiogramright ventricletricuspid valve03 medical and health sciences0302 clinical medicineClinical CaseTR - Tricuspid regurgitationmedicineDiseases of the circulatory (Cardiovascular) systemTVA tricuspid valve annuluscardiovascular diseasesSurgical repairTricuspid valvetreatmentbusiness.industryRing annuloplasty3-dimensionalTEE transesophageal echocardiographyGold standard (test)First in humanvalve repairCT computed tomographySurgerymedicine.anatomical_structureTTE transthoracic echocardiographyRC666-701cardiovascular systemTV tricuspid valveCardiology and Cardiovascular MedicinebusinessRCA right coronary artery030217 neurology & neurosurgeryJACC: Case Reports
researchProduct

12‐Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation

2021

Objectives We investigated the durability of tricuspid regurgitation (TR) reduction and the clinical outcomes through 12 months after transcatheter tricuspid valve repair (TTVr) with the PASCAL Transcatheter Valve Repair System. Background TTVr has rapidly developed and demonstrated favorable acute outcomes, but longer follow-up data are needed. Methods Overall, 30 patients (age 77 ± 6 years; 57% female) received PASCAL implantation from September 2017 to May 2019 and completed a clinical follow-up at 12 months. Results The TR etiology was functional in 25 patients (83%), degenerative in three (10%), and mixed in two (7%). All patients had TR severe or greater (massive or torrential in 80%)…

MaleCardiac Catheterizationmedicine.medical_specialtyTime FactorsRegurgitation (circulation)030204 cardiovascular system & hematologytranscatheter tricuspid valve intervention PASCAL 12-month outcomes severe tricuspid regurgitation right-sided heart failure03 medical and health sciences0302 clinical medicinemedicineHumansEndocarditisRadiology Nuclear Medicine and imagingddc:610030212 general & internal medicineTRICUSPID VALVE REPAIRStrokeSurvival rateAgedAged 80 and overHeart Valve Prosthesis Implantationbusiness.industryPascal (unit)General Medicinemedicine.diseaseTricuspid Valve InsufficiencySurgeryTreatment OutcomeHeart failureEtiologyFemaleTricuspid ValveCardiology and Cardiovascular MedicinebusinessCatheterization and Cardiovascular Interventions
researchProduct

Pulmonary vascular resistance versus pulmonary artery pressure for predicting right ventricular remodeling and functional tricuspid regurgitation.

2018

BACKGROUND Pulmonary hypertension (PH) is a common cause of right ventricular (RV) remodeling and functional tricuspid regurgitation (FTR), but incremental pulmonary artery systolic pressure (PASP) does not always correlate with anatomic and functional RV changes. This study aimed to evaluate a noninvasive measure of pulmonary vascular resistance (PVR) for predicting RV dilatation, RV dysfunction, and severity of FTR. METHODS We prospectively analyzed consecutive stable patients with PASP ≥ 35 mm Hg or any degree of RV dilatation or dysfunction secondary to PH. Noninvasive PVR was calculated based on FTR peak velocity and flow in RV outflow tract. RESULTS We included 251 patients, aged 72.1…

Malemedicine.medical_specialtyHeart Ventricles030204 cardiovascular system & hematologyDoppler echocardiographyPulmonary ArteryInferior vena cavaSeverity of Illness Index03 medical and health sciences0302 clinical medicineFunctional tricuspid regurgitationmedicine.arteryInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingArterial PressureProspective StudiesVentricular remodelingAgedmedicine.diagnostic_testVentricular Remodelingbusiness.industrymedicine.diseasePulmonary hypertensioneye diseasesTricuspid Valve InsufficiencyBlood pressuremedicine.anatomical_structure030228 respiratory systemmedicine.veinEchocardiographyPulmonary arteryCardiologyVascular resistanceFemaleVascular Resistancesense organsCardiology and Cardiovascular MedicinebusinessEchocardiography (Mount Kisco, N.Y.)
researchProduct